Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.
about
Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Changes in sexual problems over time in women with and without early-stage breast cancerFirst-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?Choices for young women at intermediate risk of breast cancerQuality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen.Not all depression is created equal: sex interacts with disease to precipitate depressionHormonal therapies in young breast cancer patients: when, what and for how long?Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.Nonhormonal management of hot flashes for women on risk reduction therapy.Endocrine therapy for breast cancer in the primary care setting
P2860
Q31001228-BD95A3F8-4C47-4740-98D1-921E33512B93Q33569159-4FA4A660-8BF3-4D9D-88FA-57A28ABF4CC2Q34127028-8739B229-85C9-4AC8-8327-5C548035E830Q35622444-28E8E3F8-0C96-4E0E-ABBD-F9AB9B64DCDEQ36000212-A5FC1668-C1E7-4F78-9A14-D6A80B00FBEAQ36251684-483E68D0-317E-4AF1-82A1-8B7B8661EDFDQ36349610-F210A001-155C-403B-8BB7-9067D13BB7CBQ36508458-296172D4-5851-4B24-A288-58E5A495D9BDQ36803388-67FA801E-E6CB-44AE-A8B1-1B34A9FA2236Q36963393-7AE9C7DC-4D0B-403E-8BA9-FC1DEDF7F721Q37103134-A0030443-C405-49D6-A588-19000A406293Q37127209-614954C3-D044-43C3-850C-64725CE76749Q37579591-75BED81A-1D6A-4FBD-A29D-46EC9E903B94Q57108564-9AE6525E-43EA-4314-ABA6-ED531E17EB36
P2860
Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@en
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@nl
type
label
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@en
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@nl
prefLabel
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@en
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@nl
P1476
Quality of life and tamoxifen ...... vant Breast and Bowel Project.
@en
P2093
National Surgical Adjuvant Breast and Bowel Projet P-1 study (NSABP-1)
P304
P407
P577
2001-12-01T00:00:00Z